These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26799523)

  • 1. Effects of Long-Chain and Medium-Chain Fatty Acids on Apoptosis and Oxidative Stress in Human Liver Cells with Steatosis.
    Wang B; Li L; Fu J; Yu P; Gong D; Zeng C; Zeng Z
    J Food Sci; 2016 Mar; 81(3):H794-800. PubMed ID: 26799523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium and Long Chain Fatty Acids Differentially Modulate Apoptosis and Release of Inflammatory Cytokines in Human Liver Cells.
    Li L; Wang B; Yu P; Wen X; Gong D; Zeng Z
    J Food Sci; 2016 Jun; 81(6):H1546-52. PubMed ID: 27145239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in hepatic metabolism of long- and medium-chain fatty acids: the role of fatty acid chain length in the production of the alcoholic fatty liver.
    Lieber CS; Lefèvre A; Spritz N; Feinman L; DeCarli LM
    J Clin Invest; 1967 Sep; 46(9):1451-60. PubMed ID: 6036539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GPR84 deletion on obesity and diabetes development in mice fed long chain or medium chain fatty acid rich diets.
    Du Toit E; Browne L; Irving-Rodgers H; Massa HM; Fozzard N; Jennings MP; Peak IR
    Eur J Nutr; 2018 Aug; 57(5):1737-1746. PubMed ID: 28429080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-Chain Fatty Acid Feeding Reduces Oxidation and Causes Panacinar Steatosis in Livers of Neonatal Pigs.
    Gerrard SD; Yonke JA; McMillan RP; Sunny NE; El-Kadi SW
    J Nutr; 2024 Mar; 154(3):908-920. PubMed ID: 38253226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly expressed MT-ND3 positively associated with histological severity of hepatic steatosis.
    Wang HN; Chen HD; Chen KY; Xiao JF; He K; Xiang GA; Xie X
    APMIS; 2014 May; 122(5):443-51. PubMed ID: 24020820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
    Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexanoic, Octanoic and Decanoic Acids Promote Basal and Insulin-Induced Phosphorylation of the Akt-mTOR Axis and a Balanced Lipid Metabolism in the HepG2 Hepatoma Cell Line.
    Rial SA; Ravaut G; Malaret TB; Bergeron KF; Mounier C
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30208604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term administration of saturated and n-3 fatty acid-rich diets on lipid utilisation and oxidative stress in rat liver and muscle tissues.
    Feillet-Coudray C; Aoun M; Fouret G; Bonafos B; Ramos J; Casas F; Cristol JP; Coudray C
    Br J Nutr; 2013 Nov; 110(10):1789-802. PubMed ID: 23656726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet.
    Kim JH; Suk S; Jang WJ; Lee CH; Kim JE; Park JK; Kweon MH; Kim JH; Lee KW
    J Food Sci; 2017 Jul; 82(7):1765-1774. PubMed ID: 28608557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-chain fatty acids ameliorate insulin resistance caused by high-fat diets in rats.
    Wein S; Wolffram S; Schrezenmeir J; Gasperiková D; Klimes I; Seböková E
    Diabetes Metab Res Rev; 2009 Feb; 25(2):185-94. PubMed ID: 19219861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
    Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F
    Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
    Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medium-chain fatty acid reduces lipid accumulation by regulating expression of lipid-sensing genes in human liver cells with steatosis.
    Wang B; Fu J; Li L; Gong D; Wen X; Yu P; Zeng Z
    Int J Food Sci Nutr; 2016; 67(3):288-97. PubMed ID: 26932533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feeding medium-chain fatty acid-rich formula causes liver steatosis and alters hepatic metabolism in neonatal pigs.
    Gerrard SD; Yonke JA; Seymour KA; Sunny NE; El-Kadi SW
    Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G135-G146. PubMed ID: 37280515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
    Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
    Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 is associated with liver lipid homeostasis but not with cell death in experimental hepatic steatosis.
    Sánchez-Garrido MA; Chico Y; González R; Ranchal I; González-Rubio S; Hidalgo AB; Díaz-López C; Costán G; Padillo FJ; De la Mata M; Ochoa B; Muntané J
    Innate Immun; 2009 Dec; 15(6):337-49. PubMed ID: 19710104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.